BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Fu BB, Gale RP, Liang Y. NK-/T-cell lymphomas. Leukemia 2021;35:2460-8. [PMID: 34117356 DOI: 10.1038/s41375-021-01313-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Czegle I, Gray AL, Wang M, Liu Y, Wang J, Wappler-guzzetta EA. Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies. Life 2021;11:1351. [DOI: 10.3390/life11121351] [Reference Citation Analysis]
2 Wang Y, Wang C, Sun P, Liu P, Yang H, Wang H, Rao H, Li S, Jiang W, Huang J, Li Z. Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination. Front Oncol 2022;12:796738. [DOI: 10.3389/fonc.2022.796738] [Reference Citation Analysis]
3 Kim H, Ko YH. The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. Life (Basel) 2022;12:73. [PMID: 35054466 DOI: 10.3390/life12010073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chan JY, Lim JQ, Ong CK. Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma. Life (Basel) 2021;11:838. [PMID: 34440582 DOI: 10.3390/life11080838] [Reference Citation Analysis]
5 He C, Wang C, Liu H, Shan B. Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells. BMC Cancer 2022;22:724. [PMID: 35778693 DOI: 10.1186/s12885-022-09825-5] [Reference Citation Analysis]
6 Wu W, Chen X, Li N, Luo Q, Zou L. First-line LVDP (L-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type. Ann Hematol 2022. [PMID: 35585247 DOI: 10.1007/s00277-022-04828-5] [Reference Citation Analysis]
7 Gao Y, Feng X, Song W, Li H, Shi C, Jin M, Li Z, Zhang L, Zhang M. The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma. Hematol Oncol 2022. [PMID: 35439335 DOI: 10.1002/hon.3007] [Reference Citation Analysis]
8 Elverdi T, Hıyamlı MF, Şahin B, Eşkazan AE. A new dawn for upfront autologous SCT in NK/T-cell lymphomas: One more step forward in reasoning. Int J Cancer 2022;151:661-4. [PMID: 35678217 DOI: 10.1002/ijc.34130] [Reference Citation Analysis]